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Abstract 
Peroxynitrite may be formed in the vasculature by the reaction of superoxide with nitric oxide. When the blue copper-containing protein, 
caeruloplasmin, is incubated with peroxynitrite, copper is released, and ferroxidase activity and the blue colouration are lost. When plasma from 
normal subjects is incubated with peroxynitrite, the oxidant reacts with numerous plasma constituents but is still able to release copper from 
caeruloplasmin. As the ferroxidase activity of caeruloplasmin islost in plasma in the presence of peroxynitrite, asecond ferroxidase activity associated 
with peroxidised lipids, and not inhibited by azide, is formed. 
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1. Introduction 
Oxidation of low-density lipoproteins (LDL) is 
thought to occur in the artery wall and results in a mod- 
ified form of LDL recognised by the macrophage scaven- 
ger receptor [la]. Uptake of LDL modified in this way 
is not down-regulated and results in the formation of 
lipid-laden foam cells frequently associated with early 
atherosclerotic lesions [5]. 
The lipid moiety of LDL contains polyunsaturated 
fatty acids which are normally protected by strategically 
placed antioxidants. These may, however, be over- 
whelmed, leading to lipid peroxidation and oxidative 
modification of LDL protein [4]. 
Copper salts are extremely effective pro-oxidants in 
vitro for oxidatively modifying LDL [6]. They readily 
decompose lipid peroxides to generate aldehydic inter- 
mediates [4,6], and it is these aldehydes which are be- 
lieved to play a major role in vivo in altering LDL pro- 
tein structure leading to scavenger eceptor recognition 
[71. 
Plasma does not normally contain chelatable forms of 
copper able to participate in lipid peroxidation reactions 
[8]. Storage or mishandling of plasma, however, can 
cause such copper to be released from caeruloplasmin 
which stimulates peroxidation of plasma lipids to form 
a copper-lipoprotein complex with ferroxidase activity 
[8,91. 
* Corresponding author. 
We show here that peroxynitrite is extremely effective 
in vitro at releasing copper from caeruloplasmin, even 
when the protein is in its normal plasma environment, 
and suggest hat similar mechanisms may occur in vivo. 
2. Materials and methods 
1, IO-phenanthroline, calf thymus DNA, apotransferrin and caeru- 
loplasmin (human) were obtained from the Sigma Chemical Co., Poole, 
Dorset. All other reagents were of the highest purity available from 
Fisons Scientific Equipment, Loughborough, Leics., UK. Caeruloplas- 
min radial immunodiffusion plates were obtained from Behring- 
Hoechst, Middx., UK. 
2. I. Caeruloplasmin 
Caeruloplasmin obtained as a solution containing 50 mg/ml was 
further purified by passing it through a column (5 x 0.5 cm) of Se- 
phadex GlO, and eluting with 0.15 M NaCl, pH 7.4. Protein concentra- 
tion was determined by radial immunodiffusion, and application of the 
molar extinction coefficient for caeruloplasmin (10m4 M-’ .crn-‘) at 
A 6,0 nm. Commercially obtained caeruloplasmin treated as above 
still contained trace amounts of phenanthroline-chelatable copper 
(see Table 1). 
2.2. Peroxynitrite synthesis 
Based on the method previously described [lo], equal volumes of 2 
M NaNO, and 2.5 M H202 in 2.9 M HN09 were mixed by syringe on 
ice. The mixture (12 ml) was stabilized by the addition of 6.6 ml 4.2 M 
NaOH. Unreacted H,02 was removed by passing the solution over 
MnO,. The resulting peroxynitrite was stored frozen at -2O”C, and 
only the top yellow layer retained for use. The concentration of per- 
oxynitrite was determined by applying a molar extinction coefficient of 
1,670 M-’ cd at A,,, MI against an appropriate blank prepared from 
peroxynitrite in 0.1 M potassium phosphate buffer, pH 7.4. The latter 
procedure was also used for the preparation of peroxynitrite decompo- 
sition products. 
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2.3. Ferroxidase activities 
Total ferroxidase (Fox) activity of plasma was measured kinetically 
at 30°C as the oxidation of a ferrous salt to the ferric state and its 
loading onto apotransferrin to form the pink diferric transferrin ab- 
sorbing at 460 nm [l 11. Ferroxidase 1 activity was that part of the total 
activity inhibited by 1 mM azide. Activity is expressed as IU/ml. 
1 A Peroxynitrite decomposition products 
2.4. Measurement of chelatable copper 
Phenanthroline-chelatable copper was determined as previously de- 
scribed [8] and quantitated with reference to standards of cupric chlo- 
ride by measuring the amount of malondialdehyde r leased from DNA 
by the phenanthroline-copper complex in the presence of the reducing 
agent, mercaptoethanol. Controls were introduced to assess the amount 
of TBA-reactive material arising in incubated plasma that did not come 
from the specific DNA reaction with copper-phenanthroline. 
2.5. Incubation of native caeruloplasmin and plasma with peroxynitrite 
Caeruloplasmin (3.6 umol/l) was incubated for 90 min at 37’C with 
1.5 mmol/l peroxynitrite in 0.1 M potassium phosphate buffer, pH 7.4, 
and compared with a control incubated with decomposed peroxynitrite. 
Plasma (0.375 ml in the incubation mixture volume of 1 ml) was simi- 
larly incubated for 90 min at 37°C with peroxynitrite. 
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2.6. Total plasma thiobarbituric acid reactivity 
200 ~1 of plasma sample incubated with peroxynitrite was added to 
0.5 ml of 1% (w/v) thiobarbituric acid in 0.05 M NaOH and 0.5 ml 28% 
(w/v) trichloroacetic acid. The mixture was heated at 100°C for 10 min. 
When cool, 3 ml of butan-l-01 was added, and the tube contents vortex- 
mixed before centrifugation at 3,000 rpm for 6 min. TBA reactivity in 
the upper organic layer was measured spectrofluorimetrically against 
malondialdehyde (MDA) standards prepared from 1,1,3,3-tetrametho- 
xypropane similarly treated. 
Fig. 1. Phenanthroline-chelatable copper (umol/l) released from caeru- 
loplasmin following incubation at 37°C for 90 min with increasing 
(mmol/l) concentrations of peroxynitrite. 
3. Results 
Incubation of native caeruloplasmin with increasing 
concentrations of peroxynitrite caused a progressive re- 
lease of chelatable copper, with a concentration of 1.5 
mmol/l peroxynitrite releasing all the copper (25.1 FM) 
present in caeruloplasmin (Fig. 1 and Table 1). Coincid- 
ing with copper release from caeruloplasmin was loss of 
ferroxidase 1 activity, and loss of antibody recognition 
in a radial immunodiffusion assay (Table 1). Spectral 
changes over this time-course showed a loss of absorb- 
ance at 610 nm and an increase at 460 nm (Fig. 2). These 
changes were associated with copper release from caeru- 
loplasmin and loss of ferroxidase activity. 
subjects was pooled for analysis. In agreement with pre- 
vious studies [ 121 the plasma had a caeruloplasmin con- 
centration of 2.28 ? 0.27 pmol/l, a ferroxidase activity of 
0.780 2 0.075 IU/ml and no phenanthroline-chelatable 
copper present. Incubation of plasma (diluted 1 in 2.7 in 
the reaction) with peroxynitrite (1.5 mmol/l) at 37°C for 
90 min caused substantial release of phenanthroline- 
chelatable copper (Table 2) compared with controls. Si- 
multaneously, ferroxidase 2 activity (copper-oxidised lip- 
oprotein) increased (Table 2). Evidence consistent with 
oxidation of plasma lipids during incubation with per- 
oxynitrite, was provided by the large increase in thiobar- 
bituric acid-reactive substances compared to the controls 
(Table 2). 
4. Discussion 
Freshly taken plasma (heparinised) from three normal 
Copper salts are particularly effective in modifying 
isolated low density lipoproteins for recognition by the 
Table 1 
The effect of peroxynitrite (1.5 mmol/l) on native caeruloplasmin 
Caeruloplasmin (3.6 PmoYl) Caeruloplasmin (3.6 pmol/l) 
+ decomposition products of 
peroxynitrite 




Total ferroxidase activity @J/ml) 
Ferroxidase 1 (IU/ml) 
Ferroxidase 2 (IV/ml) 
Immunoreactive 
caeruloplasmin @mol/l) 
3.6 f 0.2 3.7 f 0.7 26.5 If: 1.2* 
0.718 + 0.029 0.697 f 0.027 0.030 Zb 0.011* 
0.679 + 0.036 0.659 t 0.032 0.001 f 0.016* 
0.038 f 0.008 0.038 + 0.006 0.029 f 0.006 
3.5 f 0.1 3.5 f 0.1 0.0 f o.o* 
Values shown are concentrations in the reaction and are the means f SD, n = 3, Student’s t-test, *P < 0.001. All samples were incubated at 37°C 
for 90 min. 
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Fig. 2. Spectral changes (400-680 nm) in caeruloplasmin (5 pmol/l) 
incubated with peroxynitrite (1.5 mmol/l) from I%90 min. 
acetyl, or scavenger, receptor of macrophages [6]. This 
may in part be explained by the ability of copper to 
decompose lipid peroxides to form aldehydes [13], and 
perhaps direct interaction with the protein. Low molecu- 
lar mass copper complexes, however, with redox active 
properties towards organic and inorganic oxygen radical 
reactions, are not present in freshly taken plasma or 
serum from normal healthy individuals [8]. Such copper, 
chelatable to 1, lo-phenanthroline, does arise, however, 
when plasma is stored or mishandled [9], and can de- 
grade DNA when redox cycled in the phenanthroline 
assay [8]. Almost all the copper present in plasma taken 
from normal healthy subjects is structurally part of the 
protein, caeruloplasmin, which contains some 6-7 cop- 
per ions per molecule. This copper is essential to the 
ferroxidase activity (oxidation of ferrous ions to the fer- 
ric state) of caeruloplasmin and, when released, causes 
oxidation of plasma lipoproteins and the appearance of 
51 
a second ferroxidase (Fox 2) [9,14,15] with an activity 
not inhibited by azide [16]. When native caeruloplasmin 
is incubated with peroxynitrite, substantial amounts of 
copper are released from the protein that can be chelated 
by 1, IO-phenanthroline and redox-cycled to damage 
DNA. As expected, copper loss caused a decrease in 
ferroxidase activity, and a loss of caeruloplasmin’s char- 
acteristic blue colour (&,, d. Since lipoproteins were 
not present, ferroxidase 2 activity was not increased. 
Incubation of freshly taken normal pooled plasma with 
peroxynitrite also caused release of phenanthroline- 
chelatable copper, representing 24% of the total copper 
present, in spite of the fact that peroxynitrite reacts with 
many other plasma constituents. The copper released in 
plasma caused the oxidation of plasma lipoproteins, in- 
creasing the amount of ferroxidase 2 activity as well as 
TBA-reactive material, although the latter is a non-spe- 
cific measure of lipid peroxidation. 
Our studies show that peroxynitrite, formed by the 
reaction of superoxide and nitric oxide, has the potential 
to release chelatable redox active copper from the major 
plasma copper-containing protein caeruloplasmin. Per- 
oxynitrite may contribute to the pathogenesis of athero- 
sclerosis by modifying LDL directly, as well as shown 
here by releasing copper from caeruloplasmin, which 
would then promote lipid peroxidation [17-l 91. Whether 
peroxynitrite is formed in the vasculature is still unclear, 
although indirect evidence supports the hypothesis that 
superoxide and nitric oxide are formed simultaneously 
in atherosclerotic lesions [20,21]. This study supports the 
idea that caeruloplasmin is a likely source of the redox- 
active copper recently detected in atherosclerotic post- 
mortem material [22], and this may have arisen as a 
consequence of direct damage by peroxynitrite. 
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Table 2 
The effect of peroxynitrite (1.5 mM) on human plasma 
Plasma before Plasma after Plasma + decomposition Plasma + peroxynitrite 
incubation incubation products of peroxynitrite 
Phenanthroline-chelatable 
copper @mol/l) 0 0.1 + 0.0 0.2 & 0.1 1.3 f 0.4** 
Total ferroxidase 
activity (IU/ml) 0.292 + 0.028 0.267 + 0.045 0.275 + 0.022 0.198 + 0.028*** 
Ferroxidase 1 (IU/mI) 0.270 f 0.013 0.248 + 0.029 0.262 + 0.006 0.143 + 0.039** 
Ferroxidase 2 (IV/ml) 0.022 It 0.014 0.019 f 0.017 0.013 + 0.017 0.055 f 0.011 
Thiobarbituric acid-reactive 
substances (TBARS) PmoYl) 0.54 f 0.18 0.44 f 0.20 0.41 f 0.14 1.64 f 0.34** 
Values shown are reaction concentrations as means f SD. Student’s t-test, n = 3, *P < 0.001, **P < 0.01, ***P < 0.05. All samples were incubated 
at 37°C for 90 min. TBARS are expressed as malondialdehyde quivalents. 
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